4,6,8-decatrienamide, 3-hydroxy-N-(6-hydroxy-9-(8-hydroxy-1-(methyoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-asaspiro(3.4)oct-8-yl)-9-methyl-2,4-nonadienyl)-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-,135094-12-1 Products Supply

Name: 4,6,8-decatrienamide, 3-hydroxy-N-(6-hydroxy-9-(8-hydroxy-1-(methyoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-asaspiro(3.4)oct-8-yl)-9-methyl-2,4-nonadienyl)-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-
CAS NO.: 135094-12-1
Synonyms:
Triedimycin A;Curromycin A;4,6,8-Decatrienamide, 3-hydroxy-N-(6-hydroxy-9-(8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro(3.4)oct-8-yl)-9-methoxy-7-methyl-2,4-nonadienyl-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-;4,6,8-decatrienamide, 3-hydroxy-N-(6-hydroxy-9-(8-hydroxy-1-(methyoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-asaspiro(3.4)oct-8-yl)-9-methyl-2,4-nonadienyl)-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-;AC1O5LBQ;97412-76-5;LS-59406;(4E,6E,8E)-3-hydroxy-N-[(2E,4E)-6-hydroxy-9-[5-hydroxy-1-(methoxymethyl)-6,8-dimethyl-3,7-dioxo-2-oxa-8-azaspiro[3.4]octan-5-yl]-9-methoxy-7-methylnona-2,4-dienyl]-2,2,4-trimethyl-10-(2-methyl-1,3-oxazol-5-yl)deca-4,6,8-trienamide;135094-12-1;4,6,8-Decatrienamide, 3-hydroxy-N-(6-hydroxy-9-(8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro(3.4)oct-8-yl)-9-methoxy-7-methyl-2,4-nonadienyl)-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-
Molecular Structure:
Molecular Formula: C₃₈H₅₅N₃O₁₀

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 4,6,8-decatrienamide, 3-hydrox; 4,6,8-Decatrienamide,3-hydroxy; 4,6,8-Decatrienamide,3-hydroxy; 4,6,8-Decatrienamide,3-hydroxy; (4E,6E,8E)-3-hydroxy-N-{(2E,4E; (4E,6E,8E)-3-hydroxy-N-[(2E,4E; 19-Oxa-1,4,7,25-tetraazabicycl; Spiro[furan-3(2H),1'(2'H)-phen; 4(1H)-Pyrimidinone,2-[1-[(2-fl; 13H-12,16-Imino-2H,5H-pyrano[3; 3-Oxazolidinecarboxylic acid,4; Bicyclo[3.2.1]oct-3-en-2-one,8; N-Methyl-4-[7-(4-cyano-3-trifl; 5-[2-[[4-(7,7-dimethyl-9-oxo-8; 1-Oxa-7-azaspiro[5.5]undecan-8; Spiro[3H-indole-3,1'(5'H)-pyrr; 2,6-dibromo-4-[7-(3,5-dibromo-; Spiro[3-cyclohexene-1,12'-[1H-; 2H-Pyran-3-carboxylic acid,4-(; 1/C7H8O3/c1-2-9-7(8)6-4-3-5-10; 2-Propynyloxycarbamic acid 7(R; Bicyclo[3.2.1]oct-3-en-2-one,8; 1/C10H8N2/c1-2-6-12-10(3-1)9-4; 2(5H)-Furanone,4-hydroxy-3-met; 2(5H)-Furanone,4-hydroxy-3-met; 1/C6H6ClNO2/c1-10-6(9)5-4(7)2-; Spiro[cyclohexane-1,4'(3'H)-[1; Glycine,N-[(1R)-2-hydroxy-3-[(; 1/C6H6O3S2/c1-2-9-5(7)4-3-10-1; 2(5H)-Furanone,5-[7-hydroxy-3-;